keyword
https://read.qxmd.com/read/38678766/efficacy-and-safety-of-phenytoin-and-levetiracetam-for-acute-symptomatic-seizures-in-children-with-acute-encephalitis-syndrome-an-open-label-randomised-controlled-trial
#61
JOURNAL ARTICLE
Indar Kumar Sharawat, Vignesh Kaniyappan Murugan, Sanjot Bhardwaj, Apurva Tomar, Lokesh Tiwari, Puneet Dhamija, Prateek Kumar Panda
INTRODUCTION: Seizures represent a significant comorbidity in children with acute encephalitis syndrome (AES). Despite this, there is a notable absence of randomized controlled trials (RCTs) directly comparing antiseizure medications (ASMs) in children with AES. MATERIALS AND METHODS: This RCT aimed to assess the efficacy and safety of phenytoin and levetiracetam in controlling seizures among children with AES. Both ASMs were administered with a loading followed by maintenance dose...
April 18, 2024: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/38678505/perampanel-for-treatment-of-people-with-a-range-of-epilepsy-aetiologies-in-clinical-practice-evidence-from-the-permit-extension-study
#62
JOURNAL ARTICLE
Adam Strzelczyk, Marta Maschio, Max C Pensel, Antonietta Coppola, Satoru Takahashi, Shuichi Izumoto, Eugen Trinka, Sheri Cappucci, Ricardo Sainz-Fuertes, Vicente Villanueva
INTRODUCTION: It is important to assess the effectiveness of an antiseizure medication in treating different epilepsy aetiologies to optimise individualised therapeutic approaches. Data from the PERaMpanel pooled analysIs of effecTiveness and tolerability (PERMIT) Extension study were used to assess the effectiveness and safety/tolerability of perampanel (PER) when used to treat individuals with a range of epilepsy aetiologies in clinical practice. METHODS: A post hoc analysis was conducted of PERMIT Extension data from individuals with a known aetiology...
April 28, 2024: Neurology and Therapy
https://read.qxmd.com/read/38678320/-advances-of-pathological-research-and-classification-in-malformations-of-cortical-development-associated-with-refractory-epilepsy
#63
REVIEW
Y J Fu, Y S Piao
With rapid development of genetic testing techniques, neuroimaging and neuroelectrophysiological technologies, our understanding of malformations of cortical development continues to be deepened and updated. In particular, mutations in genes related to the mammalian target of rapamycin (mTOR) signaling pathway have been successively discovered in focal cortical dysplasia (FCD). At the same time, the classification consensus on FCD issued by the International League Against Epilepsy (ILAE) in 2011 has encountered problems and challenges in diagnostic practice...
May 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38678123/combined-diffusion-tensor-imaging-and-quantitative-susceptibility-mapping-to-characterize-normal-appearing-white-matter-in-self-limited-epilepsy-with-centrotemporal-spikes
#64
JOURNAL ARTICLE
Gaoqiang Xu, Yao Zhang, Xiaoxi Chen
PURPOSE: In brain development, Myelination is the characteristic feature of white matter maturation, which plays an important role in efficient information transmitting. The white matter abnormality has been reported to be associated with self-limited epilepsy with centrotemporal spikes (SeLECTS). This study aimed to detect the altered white matter region in the SeLECTS patients by the combination of diffusion tensor imaging (DTI) and quantitative susceptibility mapping (QSM) technique...
April 27, 2024: Neuroradiology
https://read.qxmd.com/read/38678058/human-local-field-potentials-in-motor-and-non-motor-brain-areas-encode-upcoming-movement-direction
#65
JOURNAL ARTICLE
Etienne Combrisson, Franck Di Rienzo, Anne-Lise Saive, Marcela Perrone-Bertolotti, Juan L P Soto, Philippe Kahane, Jean-Philippe Lachaux, Aymeric Guillot, Karim Jerbi
Limb movement direction can be inferred from local field potentials in motor cortex during movement execution. Yet, it remains unclear to what extent intended hand movements can be predicted from brain activity recorded during movement planning. Here, we set out to probe the directional-tuning of oscillatory features during motor planning and execution, using a machine learning framework on multi-site local field potentials (LFPs) in humans. We recorded intracranial EEG data from implanted epilepsy patients as they performed a four-direction delayed center-out motor task...
April 27, 2024: Communications Biology
https://read.qxmd.com/read/38677953/onchocerciasis-associated-epilepsy-charting-a-path-forward
#66
REVIEW
G Van Cutsem, J N Siewe Fodjo, A Hadermann, L-J Amaral, C Trevisan, S Pion, R Colebunders
This narrative review intends to inform neurologists and public health professionals about Onchocerciasis-Associated Epilepsy (OAE), a neglected public health problem in many remote onchocerciasis-endemic areas. For epidemiological purposes, we define OAE as sudden-onset of convulsive and non-convulsive seizure types, including head nodding seizures (nodding syndrome) in a previously healthy child aged 3 to 18 years in the absence of any other obvious cause for epilepsy, all happening within an area with high ongoing Onchocerca volvulus transmission...
April 21, 2024: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/38677803/building-a-pediatric-neurocritical-care-program-the-role-of-the-clinical-pharmacist-practitioner-on-clinical-practice-and-education-a-curriculum-for-neuropharmacology-training
#67
REVIEW
Jon A Cokley, Steven M Lazar
Clinical pharmacists are a part of the integrated health care team and provide valuable input on medication management for patients with acute and chronic disease states. Using epilepsy as a model, pharmacist involvement in patient care has been associated with significant reductions in monthly seizure frequency. Given differences in etiology, pediatric patients with epilepsy are likely to have higher number of treatments, with additional pharmacodynamic and pharmacokinetic differences, adding to the importance of utilizing a pediatric clinical pharmacist practitioner with neuropharmacology expertise...
April 2024: Seminars in Pediatric Neurology
https://read.qxmd.com/read/38677573/phytocannabinoids-in-neuromodulation-from-omics-to-epigenetics
#68
REVIEW
Subhadip Banerjee, Debolina Saha, Rohit Sharma, Wuttichai Jayadee, Panupong Puttarak, Nathorn Chaiyakunapruk, Rawiwan Chaoroensup
BACKGROUND: Recent developments in metabolomics, transcriptomic and epigenetics open up new horizons regarding the pharmacological understanding of phytocannabinoids as neuromodulators in treating anxiety, depression, epilepsy, Alzheimer's, Parkinson's disease and autism. METHODS: The present review is an extensive search in public databases, such as Google Scholar, Scopus, the Web of Science, and PubMed, to collect all the literature about the neurobiological roles of cannabis extract, cannabidiol, 9-tetrahydrocannabinol specially focused on metabolomics, transcriptomic, epigenetic, mechanism of action, in different cell lines, induced animal models and clinical trials...
April 25, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38677543/characterization-number-and-spatial-organization-of-nerve-fibers-in-the-human-cervical-vagus-nerve-and-its-superior-cardiac-branch
#69
JOURNAL ARTICLE
Bettina Kronsteiner, Genova Carrero-Rojas, Lukas F Reissig, Atieh Seyedian Moghaddam, Karoline M Schwendt, Sylvia Gerges, Udo Maierhofer, Oskar C Aszmann, Angel M Pastor, Attila Kiss, Bruno K Podesser, Wolfgang Birkfellner, Francesco Moscato, Roland Blumer, Wolfgang J Weninger
BACKGROUND: Electrical stimulation of the vagus nerve (VN) is a therapy for epilepsy, obesity, depression, and heart diseases. However, whole nerve stimulation leads to side effects. We examined the neuroanatomy of the mid-cervical segment of the human VN and its superior cardiac branch to gain insight into the side effects of VN stimulation and aid in developing targeted stimulation strategies. METHODS: Nerve specimens were harvested from eight human body donors, then subjected to immunofluorescence and semiautomated quantification to determine the signature, quantity, and spatial distribution of different axonal categories...
April 25, 2024: Brain Stimulation
https://read.qxmd.com/read/38677102/psychiatric-complications-following-seeg-guided-radiofrequency-thermocoagulations-in-patients-with-drug-resistant-epilepsy
#70
JOURNAL ARTICLE
Marianna Bregianni, Francesca Pizzo, Stanislas Lagarde, Julia Makhalova, Agnes Trebuchon, Romain Carron, Lisa Soncin, Marie Arthuis, Fabrice Bartolomei
SEEG-guided radiofrequency thermocoagulation (RF-TC) in the epileptogenic regions is a therapeutic option for patients with drug-resistant focal epilepsy who may have or not indication for epilepsy surgery. The most common adverse events of RF-TC are seizures, headaches, somatic pain, and sensory-motor deficits. If RF-TC could lead to psychiatric complications is unknown. In the present study, seven out of 164 patients (4.2 %) experienced psychiatric decompensation with or without memory deterioration after RF-TC of bilateral or unilateral amygdala and hippocampus...
April 26, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38677101/placebo-response-in-patients-with-dravet-syndrome-post-hoc-analysis-of-two-clinical-trials
#71
JOURNAL ARTICLE
Orrin Devinsky, Kerry Hyland, Rachael Loftus, Charlotte Nortvedt, Rima Nabbout
OBJECTIVE: Dravet syndrome is a rare, early childhood-onset epileptic and developmental encephalopathy. Responses to placebo in clinical trials for epilepsy therapies range widely, but factors influencing placebo response remain poorly understood. This study explored placebo response and its effects on safety, efficacy, and quality of life outcomes in patients with Dravet syndrome. METHODS: We performed exploratory post-hoc analyses of pooled data from placebo-treated patients from the GWPCARE 1B and GWPCARE 2 randomized controlled phase III trials, comparing cannabidiol and matched placebo in 2-18 year old Dravet syndrome patients...
April 26, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38677032/generation-and-characterization-of-six-human-induced-pluripotent-stem-cell-lines-hipscs-from-three-individuals-with-ssadh-deficiency-and-crispr-corrected-isogenic-controls
#72
JOURNAL ARTICLE
Wardiya Afshar-Saber, Cidi Chen, Nicole A Teaney, Kristina Kim, Ziqin Yang, Federico M Gasparoli, Darius Ebrahimi-Fakhari, Elizabeth D Buttermore, Ivy Pin-Fang Chen, Phillip L Pearl, Mustafa Sahin
Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) is an ultra-rare autosomal recessive neurometabolic disorder caused by ALDH5A1 mutations presenting with autism and epilepsy. Here, we report the generation and characterization of human induced pluripotent stem cells (hiPSCs) derived from fibroblasts of three unrelated SSADHD patients - one female and two males with the CRISPR-corrected isogenic controls. These individuals are clinically diagnosed and are being followed in a longitudinal clinical study...
April 21, 2024: Stem Cell Research
https://read.qxmd.com/read/38677001/the-suppressive-effect-of-the-specific-kcc2-modulator-clp290-on-seizure-in-mice
#73
JOURNAL ARTICLE
Jingyi Cai, Zhuoyi Wu, Guoxiang Wang, Xiran Zhao, Xiaohan Wang, Benjamin H Wang, Jiangning Yu, Xu Liu, Yun Wang
Epilepsy is a chronic neurological disorder characterized by episodic dysfunction of central nervous system. The most basic mechanism of epilepsy falls to the imbalance between excitation and inhibition. In adults, GABAA receptor (GABAA R) is the main inhibitory receptor to prevent neurons from developing hyperexcitability, while its inhibition relies on the low intracellular chloride anion concentration ([Cl- ]i ). Neuronal-specific electroneutral K+ -Cl- cotransporter (KCC2) can mediate chloride efflux to lower [Cl- ]i for GABAA R mediated inhibition...
April 16, 2024: Epilepsy Research
https://read.qxmd.com/read/38676921/nonadherence-to-antiseizure-medications-what-have-we-learned-and-what-can-be-done-next
#74
REVIEW
Sinaa Al-Aqeel
INTRODUCTION: Nonadherence to antiseizure medications (ASMs) is associated with increased mortality, morbidity, health care utilization and costs. AREAS COVERED: This article reviewed 18 randomized controlled trials published between Jan 2010 and Feb 2024 on Medication Adherence Enhancing Intervention (MAEI) for people with epilepsy. The adequacy of reporting intervention development process was assessed using the GUIDance for the rEporting of intervention Development (GUIDED)...
April 27, 2024: Expert Review of Pharmacoeconomics & Outcomes Research
https://read.qxmd.com/read/38676719/periventricular-nodular-heterotopia-in-patients-with-a-prenatal-diagnosis-of-myelomeningocele-myeloschisis-associations-with-seizures-and-neurodevelopmental-outcomes-during-early-childhood
#75
JOURNAL ARTICLE
Tracy M Flanders, Jane E Schreiber, Maria A Punchak, Sierra D Land, Tom A Reynolds, Shelly Soni, N Scott Adzick, Gregory G Heuer
PURPOSE: Historically, the presence of gray matter heterotopia was a concern for adverse postnatal neurocognitive status in patients undergoing fetal closure of open spinal dysraphism. The purpose of this study was to evaluate neurodevelopmental outcomes and the onset of seizures during early childhood in patients with a prenatal diagnosis of myelomeningocele/myeloschisis (MMC) and periventricular nodular heterotopia (PVNH). METHODS: All patients evaluated at the Center for Fetal Diagnosis and Treatment with a diagnosis of MMC between June 2016 to March 2023 were identified...
April 27, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38676679/-long-term-follow-up-of-adult-patients-with-serial-and-status-course-of-epileptic-seizures
#76
JOURNAL ARTICLE
A S Kotov, K V Firsov
OBJECTIVE: To study the follow-up of adult patients with status epilepticus or a history of serial seizures, assessing the likelihood of achieving long-term remission and identifying predictors of treatment effectiveness. MATERIAL AND METHODS: The study included 280 patients divided into 137 patients with epilepsy with a series of seizures or a history of status epilepticus (group 1) and 143 patients, who had not previously received therapy and did not have a series of seizures or a history of status epilepticus (group 2)...
2024: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38676299/circrna-associated-cerna-regulatory-networks-as-emerging-mechanisms-governing-the-development-and-biophysiopathology-of-epilepsy
#77
REVIEW
Maryam Kohansal, Yasemin Khudiar Alghanimi, Shaimaa R Banoon, Abdolmajid Ghasemian, Hamed Afkhami, Abdolreza Daraei, Zhangling Wang, Najmeh Nekouian, Jindong Xie, Xinpei Deng, Hailin Tang
The etiology of epilepsy is ascribed to the synchronized aberrant neuronal activity within the brain. Circular RNAs (circRNAs), a class of non-coding RNAs characterized by their circular structures and covalent linkage, exert a substantial influence on this phenomenon. CircRNAs possess stereotyped replication, transience, repetitiveness, and paroxysm. Additionally, MicroRNA (miRNA) plays a crucial role in the regulation of diverse pathological processes, including epilepsy. CircRNA is of particular significance due to its ability to function as a competing endogenous RNA, thereby sequestering or inhibiting miRNA activity through binding to target mRNA...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38675435/improved-chemical-and-radiochemical-synthesis-of-neuropeptide-y-y-2-receptor-antagonist-n-methyl-jnj-31020028-and-preclinical-positron-emission-tomography-studies
#78
JOURNAL ARTICLE
Inês C F Fonseca, Mariana Lapo Pais, Fábio M S Rodrigues, José Sereno, Miguel Castelo-Branco, Cláudia Cavadas, Mariette M Pereira, Antero J Abrunhosa
Neuropeptide Y (NPY) is one of the most abundant peptides in the central nervous system of mammals and is involved in several physiological processes through NPY Y1 , Y2 , Y4 and Y5 receptors. Of those, the Y2 receptor has particular relevance for its autoreceptor role in inhibiting the release of NPY and other neurotransmitters and for its involvement in relevant mechanisms such as feeding behaviour, cognitive processes, emotion regulation, circadian rhythms and disorders such as epilepsy and cancer. PET imaging of the Y2 receptor can provide a valuable platform to understand this receptor's functional role and evaluate its potential as a therapeutic target...
April 8, 2024: Pharmaceuticals
https://read.qxmd.com/read/38674371/an-ultra-rare-mixed-phenotype-with-combined-ap-4-and-erf-mutations-the-first-report-in-a-pediatric-patient-and-a-literature-review
#79
REVIEW
Alessandro Orsini, Andrea Santangelo, Alessandra Carmignani, Anna Camporeale, Francesco Massart, Nina Tyutyusheva, Diego Giampietro Peroni, Thomas Foiadelli, Alessandro Ferretti, Benedetta Toschi, Silvia Romano, Alice Bonuccelli
The adaptor protein 4 (AP-4) constitutes a conserved hetero-tetrameric complex within the family of adaptor protein (AP) complex, crucial for the signal-mediated trafficking of integral membrane proteins. Mutations affecting all subunits of the AP-4 complex have been linked to autosomal-recessive cerebral palsy and a complex hereditary spastic paraparesis (HSP) phenotype. Our report details the case of a 14-year-old boy born to consanguineous parents, presenting psychomotor delay, severe intellectual disability, microcephaly, and trigonocephaly...
March 29, 2024: Genes
https://read.qxmd.com/read/38674365/phenotypic-description-of-a-patient-with-odluro-syndrome-and-functional-characterization-of-the-pathogenetic-role-of-a-synonymous-variant-c-186g-a-in-kmt2e-gene
#80
JOURNAL ARTICLE
Mario Benvenuto, Sofia Cesarini, Giulia Severi, Enrico Ambrosini, Angelo Russo, Marco Seri, Pietro Palumbo, Orazio Palumbo, Marco Castori, Emanuele Panza, Massimo Carella
O'Donnell-Luria-Rodan (ODLURO) syndrome is an autosomal dominant disorder caused by mutations in the KMT2E gene. The clinical phonotype of the affected individuals is typically characterized by global developmental delay, autism, epilepsy, hypotonia, macrocephaly, and very mild dysmorphic facial features. In this report, we describe the case of a 6-year-old boy with ODLURO syndrome who is a carrier of the synonymous mutation c.186G>A (p.Ala62=) in the KMT2E gene, predicted to alter splicing by in silico tools...
March 29, 2024: Genes
keyword
keyword
1042
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.